Slideshows Images Quizzes

Carafate Suspension

Last reviewed on RxList: 9/26/2016
Carafate Suspension Side Effects Center

Last reviewed on RxList 7/11/2017

Carafate (sucralfate) is an anti-ulcer medication used to treat duodenal ulcers. Carafate is available in generic form. Common side effects of Carafate include:

  • constipation,
  • diarrhea,
  • nausea,
  • vomiting,
  • upset stomach,
  • stomach pain,
  • indigestion,
  • gas,
  • dry mouth,
  • itching or skin rash,
  • sleep problems (insomnia),
  • dizziness,
  • drowsiness,
  • spinning sensation,
  • headache,
  • back pain,
  • or, hypersensitivity reactions (shortness of breath, lip swelling, and hives).

Carafate is administered orally in the form of tablets. Lower than usual dosages are recommended for elderly patients and adolescents. Drug interactions of Carafate may include reactions with other drugs taken at the same time, preventing their full absorption. It is best to take other drugs 2 hours before or after sucralfate to avoid drug interactions. Tell your doctor if you are taking cimetidine, digoxin, levothyroxine, phenytoin, quinidine, ranitidine, tetracycline, theophylline, blood thinners, certain antibiotics, and all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant during treatment with Carafate. Carafate is not expected to be harmful to a fetus. It is unknown if Carafate passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding.

Our Carafate Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Carafate Suspension Consumer Information

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Less serious side effects may include:

  • nausea, vomiting, upset stomach;
  • stomach pain;
  • constipation, diarrhea;
  • mild itching or skin rash;
  • sleep problems (insomnia);
  • dizziness, drowsiness, spinning sensation;
  • headache; or
  • back pain.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Carafate Suspension (Sucralfate)

Carafate Suspension Professional Information

SIDE EFFECTS

Adverse reactions to sucralfate tablets in clinical trials were minor and only rarely led to discontinuation of the drug. In studies involving over 2700 patients treated with sucralfate, adverse effects were reported in 129 (4.7%).

Constipation was the most frequent complaint (2%). Other adverse effects reported in less than 0.5% of the patients are listed below by body system:

Gastrointestinal: diarrhea, dry mouth, flatulence, gastric discomfort, indigestion, nausea, vomiting Dermatological: pruritus, rash

Nervous System: dizziness, insomnia, sleepiness, vertigo

Other: back pain, headache

Post-marketing cases of hypersensitivity have been reported with the use of sucralfate suspension, including anaphylactic reactions, dyspnea, lip swelling, edema of the mouth, pharyngeal edema, pruritus, rash, swelling of the face and urticaria.

Cases of bronchospasm, laryngeal edema and respiratory tract edema have been reported with an unknown oral formulation of sucralfate.

Cases of hyperglycemia have been reported with sucralfate

Bezoars have been reported in patients treated with sucralfate. The majority of patients had underlying medical conditions that may predispose to bezoar formation (such as delayed gastric emptying) or were receiving concomitant enteral tube feedings.

Inadvertent injection of insoluble sucralfate and its insoluble excipients has led to fatal complications, including pulmonary and cerebral emboli. Sucralfate is not intended for intravenous administration.

Read the entire FDA prescribing information for Carafate Suspension (Sucralfate)

Related Resources for Carafate Suspension

Read the Carafate Suspension User Reviews »

© Carafate Suspension Patient Information is supplied by Cerner Multum, Inc. and Carafate Suspension Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors